Chimerix Investor Relations Material
Latest events
FDA Announcement
Chimerix
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Chimerix Inc
Access all reports
Chimerix Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for life-threatening diseases, including viral infections and cancer. The company's portfolio includes antiviral treatments and oncology therapies aimed at addressing unmet medical needs. Chimerix works on developing novel drug candidates to improve outcomes for patients with limited treatment options, particularly in areas such as immunotherapy and targeted therapies. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Key slides for Chimerix Inc
FDA Announcement
Chimerix Inc
FDA Announcement
Chimerix Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
CMRX
Country
🇺🇸 United States